91 related articles for article (PubMed ID: 7941780)
1. Opioid peptides selective for receptor types modulate cocaine-induced behavioral responses in mice.
Ukai M; Mizutani M; Kameyama T
Nihon Shinkei Seishin Yakurigaku Zasshi; 1994 Jun; 14(3):153-9. PubMed ID: 7941780
[TBL] [Abstract][Full Text] [Related]
2. Differential modulation of behavioral responses by [D-Ala2, NMePhe4, Gly-ol]enkephalin, [D-Ala2] deltorphin II and [D-Pen2, L-Pen5]enkephalin in the mouse.
Ukai M; Toyoshi T; Mizutani M; Sasaki Y; Kameyama T
Nihon Shinkei Seishin Yakurigaku Zasshi; 1994 Jun; 14(3):161-8. PubMed ID: 7941781
[TBL] [Abstract][Full Text] [Related]
3. DAMGO ([D-Ala2,NMePhe4,Gly-ol]enkephalin), but not DPLPE ([D-Pen2,L- Pen5]enkephalin), specifically inhibits methamphetamine-induced behavioral responses in the mouse.
Ukai M; Toyoshi T; Kameyama T
Neuropharmacology; 1993 Oct; 32(10):1019-24. PubMed ID: 8295712
[TBL] [Abstract][Full Text] [Related]
4. Intrastriatal injection of opioid receptor agonists inhibits apomorphine-induced behavior in 6-hydroxydopamine-treated mice.
Toyoshi T; Ukai M; Kameyama T
Eur J Pharmacol; 1995 Dec; 294(2-3):637-43. PubMed ID: 8750728
[TBL] [Abstract][Full Text] [Related]
5. Dynorphin A-(1-13) potently improves the impairment of spontaneous alternation performance induced by the mu-selective opioid receptor agonist DAMGO in mice.
Itoh J; Ukai M; Kameyama T
J Pharmacol Exp Ther; 1994 Apr; 269(1):15-21. PubMed ID: 7909556
[TBL] [Abstract][Full Text] [Related]
6. Receptor-selective opioid peptides fail to affect behavioral responses induced by a low dose of apomorphine in the mouse.
Ukai M; Toyoshi T; Kameyama T
Pharmacol Biochem Behav; 1993 Nov; 46(3):587-91. PubMed ID: 7904071
[TBL] [Abstract][Full Text] [Related]
7. Combination of a delta opioid receptor agonist but not a mu opioid receptor agonist with the D1-selective dopamine receptor agonist SKF 38393 markedly potentiates different behaviors in mice.
Toyoshi T; Ukai M; Kameyama T
Eur J Pharmacol; 1992 Mar; 213(1):25-30. PubMed ID: 1354161
[TBL] [Abstract][Full Text] [Related]
8. [D-Ala2,NMePhe4,Gly-ol5]enkephalin, but not [D-Pen2,L-Pen5]enkephalin, specifically inhibits behaviors induced by the dopamine D2 agonist RU 24213.
Toyoshi T; Ukai M; Kameyama T
Eur J Pharmacol; 1991 Aug; 201(1):41-6. PubMed ID: 1686589
[TBL] [Abstract][Full Text] [Related]
9. Evidence for delta opioid receptor subtypes in rat spinal cord: studies with intrathecal naltriben, cyclic[D-Pen2, D-Pen5] enkephalin and [D-Ala2, Glu4]deltorphin.
Stewart PE; Hammond DL
J Pharmacol Exp Ther; 1993 Aug; 266(2):820-8. PubMed ID: 8394918
[TBL] [Abstract][Full Text] [Related]
10. Opioid receptor agonists selective for mu and kappa receptors attenuate methamphetamine-induced behavioral sensitization in the mouse.
Toyoshi T; Ukai M; Kameyama T
Biol Pharm Bull; 1996 Mar; 19(3):369-74. PubMed ID: 8924903
[TBL] [Abstract][Full Text] [Related]
11. Cocaine-like discriminative stimulus properties of the delta-selective opioid receptor agonist, [D-Pen2,L-Pen5]enkephalin, in the rat.
Ukai M; Mori E; Kameyama T
Eur J Pharmacol; 1993 Jan; 231(1):143-4. PubMed ID: 8383062
[TBL] [Abstract][Full Text] [Related]
12. Effects of [D-Ala2, D-Leu5]enkephalin and [D-Pen2, L-Pen5]enkephalin on apomorphine-induced motor activity in the mouse.
Ukai M; Toyoshi T; Kameyama T
Pharmacol Biochem Behav; 1992 Jan; 41(1):171-6. PubMed ID: 1311454
[TBL] [Abstract][Full Text] [Related]
13. Behavioral effects of opioid peptides selective for mu or delta receptors. II. Locomotor activity in nondependent and morphine-dependent rats.
Locke KW; Holtzman SG
J Pharmacol Exp Ther; 1986 Sep; 238(3):997-1003. PubMed ID: 3018231
[TBL] [Abstract][Full Text] [Related]
14. Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord.
He L; Lee NM
J Pharmacol Exp Ther; 1998 Jun; 285(3):1181-6. PubMed ID: 9618421
[TBL] [Abstract][Full Text] [Related]
15. Multi-dimensional analysis of behavior in mice treated with the delta opioid agonists DADL (D-Ala2-D-Leu5-enkephalin) and DPLPE (D-Pen2-L-Pen5-enkephalin).
Ukai M; Toyoshi T; Kameyama T
Neuropharmacology; 1989 Oct; 28(10):1033-9. PubMed ID: 2554179
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of clocinnamox blockade of opioid receptors: evidence from in vitro and ex vivo binding and behavioral assays.
Zernig G; Burke T; Lewis JW; Woods JH
J Pharmacol Exp Ther; 1996 Oct; 279(1):23-31. PubMed ID: 8858971
[TBL] [Abstract][Full Text] [Related]
17. Behavioral and neurochemical effects of opioids in the paramedian midbrain tegmentum including the median raphe nucleus and ventral tegmental area.
Klitenick MA; Wirtshafter D
J Pharmacol Exp Ther; 1995 Apr; 273(1):327-36. PubMed ID: 7714785
[TBL] [Abstract][Full Text] [Related]
18. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens.
Hirose N; Murakawa K; Takada K; Oi Y; Suzuki T; Nagase H; Cools AR; Koshikawa N
Neuroscience; 2005; 135(1):213-25. PubMed ID: 16111831
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of intrathecally administered delta and mu opioid receptor agonists on formalin-evoked nociception and on the expression of Fos-like immunoreactivity in the spinal cord of the rat.
Hammond DL; Wang H; Nakashima N; Basbaum AI
J Pharmacol Exp Ther; 1998 Jan; 284(1):378-87. PubMed ID: 9435201
[TBL] [Abstract][Full Text] [Related]
20. Selective and interactive down-regulation of mu- and delta-opioid receptors in human neuroblastoma SK-N-SH cells.
Baumhaker Y; Gafni M; Keren O; Sarne Y
Mol Pharmacol; 1993 Aug; 44(2):461-7. PubMed ID: 8394999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
